Combined oral contraceptive pills versus monthly combined injectable contraceptives regarding their menstrual and non menstrual side effects / Entsar Mamdouh Mohamed Mahmud , Supervised Hassan Omar Ghareeb , Ghada Mahmud Khafajy
نوع المادة :
نصاللغة: الإنجليزية تفاصيل النشر: Cairo : Entsar Mamdouh Mohamed Mahmud , 2016الوصف: 104 P. : charts , facsimiles ; 25cmعنوان آخر: - حبوب منع الحمبل المركبة مقابل حقن منع الحمل المركبة الشهرية فيما يتعلق بالأثار الجانبية المتعلقة وغير المتعلقة بالحيض [عنوان مضاف عنوان الصفحة]
- Issued also as CD
| نوع المادة | المكتبة الحالية | المكتبة الرئيسية | رقم الاستدعاء | رقم النسخة | حالة | الباركود | |
|---|---|---|---|---|---|---|---|
Thesis
|
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.35.M.Sc.2016.En.C (استعراض الرف(يفتح أدناه)) | لا تعار | 01010110072836000 | ||
CD - Rom
|
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.35.M.Sc.2016.En.C (استعراض الرف(يفتح أدناه)) | 72836.CD | لا تعار | 01020110072836000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Family Medicine
Background: Combined oral contraceptive pill has been the short-acting hormonal contraceptive of choice for the last 50 years. However, for some women this may not be a suitable or optimal contraceptive choice due to the side effects. The development of better tolerated methods as monthly injectable contraception is of particular importance where no daily attention is preferred, thus improving compliance. Objectives: To assess and compare the side effects of oral combined contraceptive pills versus monthly combined contraceptive injections regarding their menstrual and non-menstrual side effects. Methodology: This is a prospective comparative study that was carried on a sample of 100 clients, attending two selected family medicine units (Gezera Elmasada and Mydoum) in Beni Suef Governorate and seeking for a contraceptive method. The participants were chosen by purposive sampling technique according to inclusion criteria. Clients were divided into two groups (A and B groups). Group A: received combined oral contraceptive pills. Progestogen-estrogen combination for oral contraception (Microcept tablets) Group B: received monthly combined injectable contraceptives. Each 1 ml Mesocept ampule contains 50 mg norethisterone enanthate and 5 mg estradiol valerate in oily solution. Clients were followed for 6 months and were interviewed monthly to assess the side effects
Issued also as CD
لا توجد تعليقات على هذا العنوان.